258 related articles for article (PubMed ID: 16118076)
21. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up.
Scholefield JH; Moss SM; Mangham CM; Whynes DK; Hardcastle JD
Gut; 2012 Jul; 61(7):1036-40. PubMed ID: 22052062
[TBL] [Abstract][Full Text] [Related]
22. [Diagnosis of colorectal carcinoma. An update].
Schneider AR; Caspary WF
Radiologe; 2003 Feb; 43(2):105-12. PubMed ID: 12624667
[TBL] [Abstract][Full Text] [Related]
23. Appropriateness of colonoscopy in Europe (EPAGE II). Screening for colorectal cancer.
Arditi C; Peytremann-Bridevaux I; Burnand B; Eckardt VF; Bytzer P; Agréus L; Dubois RW; Vader JP; Froehlich F; Pittet V; Schusselé Filliettaz S; Juillerat P; Gonvers JJ;
Endoscopy; 2009 Mar; 41(3):200-8. PubMed ID: 19280531
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic yield in a biennial Hemoccult-II screening program compared to a once-only screening with flexible sigmoidoscopy and Hemoccult-II.
Rasmussen M; Fenger C; Kronborg O
Scand J Gastroenterol; 2003 Jan; 38(1):114-8. PubMed ID: 12608473
[TBL] [Abstract][Full Text] [Related]
25. Colorectal cancer mass screening event utilising quantitative faecal occult blood test.
Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW
Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676
[TBL] [Abstract][Full Text] [Related]
26. [Arguments against implementing a population-based screening programme for colorectal cancer].
Bonneux L
Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
[TBL] [Abstract][Full Text] [Related]
27. [Screening for colorectal cancer. Collaboration among politicians and scientists is necessary].
Bretthauer M; Ekbom A; Malila N; Stefánsson T; Fischer A; Hof G; Weiderpass E; Tretli S; Tryggvadóttir L; Storm H; Holten I; Adam HO
Laeknabladid; 2006; 92(7-8):521-4. PubMed ID: 16818999
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004.
Malila N; Anttila A; Hakama M
J Med Screen; 2005; 12(1):28-32. PubMed ID: 15814016
[TBL] [Abstract][Full Text] [Related]
30. [Randomized population study of screening for intestinal cancer with Hemoccult-II].
Kronborg O; Fenger C; Olsen J; Jørgensen OD; Søndergaard O
Ugeskr Laeger; 1997 Aug; 159(33):4977-81. PubMed ID: 9281212
[TBL] [Abstract][Full Text] [Related]
31. Attitudes, knowledge and practice of CRC screening among GPs in Queensland.
Youl PH; Jackson C; Oldenburg B; Brown C; Dunn J; Aitken J
Aust Fam Physician; 2006 Jul; 35(7):547-50. PubMed ID: 16820832
[TBL] [Abstract][Full Text] [Related]
32. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
Inadomi JM
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
[TBL] [Abstract][Full Text] [Related]
33. [Mass screening for colorectal cancer].
Faivre J; Tazi MA; Launoy G
Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S7-14. PubMed ID: 8935859
[TBL] [Abstract][Full Text] [Related]
34. [Colorectal cancer screening: advice from the Health Council of the Netherlands].
van Veen W; Mali WP
Ned Tijdschr Geneeskd; 2009; 153():A1441. PubMed ID: 20003552
[TBL] [Abstract][Full Text] [Related]
35. Population-based screening for colorectal cancer: Australian research and implementation.
Young GP
J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S33-42. PubMed ID: 19799696
[TBL] [Abstract][Full Text] [Related]
36. Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable.
Levin B; Smith RA; Feldman GE; Colditz GA; Fletcher RH; Nadel M; Rothenberger DA; Schroy PS; Vernon SW; Wender R;
Cancer; 2002 Oct; 95(8):1618-28. PubMed ID: 12365008
[TBL] [Abstract][Full Text] [Related]
37. Improving colorectal cancer screening by targeting office systems in primary care practices: disseminating research results into clinical practice.
Wei EK; Ryan CT; Dietrich AJ; Colditz GA
Arch Intern Med; 2005 Mar; 165(6):661-6. PubMed ID: 15795343
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
39. A 25-year follow-up of a population screened with faecal occult blood test in Finland.
Malila N; Hakama M; Pukkala E
Acta Oncol; 2007; 46(8):1103-6. PubMed ID: 17851857
[TBL] [Abstract][Full Text] [Related]
40. Colorectal cancer test use--Maryland, 2002-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
